Literature DB >> 18519245

Thiocyanate concentration in saliva of cystic fibrosis patients.

Łukasz Minarowski1, Dorota Sands, Alina Minarowska, Alicja Karwowska, Anetta Sulewska, Marek Gacko, Elzbieta Chyczewska.   

Abstract

Thiocyanates (SCN-) are ubiquitous in nature. There are indispensable part of host defense system that act as a substrate for lactoperoxidase (LPO). In our study we present initial data on SCN- concentration in saliva of CF patients in comparison to healthy non-smokers and healthy smokers. 5 ml of saliva was collected from each subject to a sterile tube and thiocyanate concentration was measured in each sample. The results of the measurements are presented on Fig. 1. Mean concentration of SCN- in saliva of CF patients was 0.031 +/- 0.0052 g/l, in healthy non-smokers 0.039 +/- 0.0048 g/l and in healthy smokers 0.048 +/- 0.0161 g/l. The differences between each group were statistically significant. Studies on larger group of patients and probably on different material (BALF or induced sputum) should present interesting data complementing the in vitro studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18519245     DOI: 10.2478/v10042-008-0037-0

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  15 in total

Review 1.  Redox balance in cystic fibrosis.

Authors:  Assem G Ziady; Jason Hansen
Journal:  Int J Biochem Cell Biol       Date:  2014-03-20       Impact factor: 5.085

Review 2.  Biochemical mechanisms and therapeutic potential of pseudohalide thiocyanate in human health.

Authors:  Joshua D Chandler; Brian J Day
Journal:  Free Radic Res       Date:  2015-01-28

3.  The thiocyanate analog selenocyanate is a more potent antimicrobial pro-drug that also is selectively detoxified by the host.

Authors:  Brian J Day; Preston E Bratcher; Joshua D Chandler; Matthew B Kilgore; Elysia Min; John J LiPuma; Robert J Hondal; David P Nichols
Journal:  Free Radic Biol Med       Date:  2019-11-15       Impact factor: 7.376

4.  Selective metabolism of hypothiocyanous acid by mammalian thioredoxin reductase promotes lung innate immunity and antioxidant defense.

Authors:  Joshua D Chandler; David P Nichols; Jerry A Nick; Robert J Hondal; Brian J Day
Journal:  J Biol Chem       Date:  2013-04-29       Impact factor: 5.157

5.  Antiinflammatory and Antimicrobial Effects of Thiocyanate in a Cystic Fibrosis Mouse Model.

Authors:  Joshua D Chandler; Elysia Min; Jie Huang; Cameron S McElroy; Nina Dickerhof; Tessa Mocatta; Ashley A Fletcher; Christopher M Evans; Liping Liang; Manisha Patel; Anthony J Kettle; David P Nichols; Brian J Day
Journal:  Am J Respir Cell Mol Biol       Date:  2015-08       Impact factor: 6.914

6.  Nebulized thiocyanate improves lung infection outcomes in mice.

Authors:  J D Chandler; E Min; J Huang; D P Nichols; B J Day
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

7.  Determination of thiocyanate in exhaled breath condensate.

Authors:  Joshua D Chandler; Hamed Horati; Douglas I Walker; Enea Pagliano; Rabindra Tirouvanziam; Mieke Veltman; Bob J Scholte; Hettie M Janssens; Young-Mi Go; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2018-08-22       Impact factor: 7.376

8.  Thiocyanate: a potentially useful therapeutic agent with host defense and antioxidant properties.

Authors:  Joshua D Chandler; Brian J Day
Journal:  Biochem Pharmacol       Date:  2012-08-08       Impact factor: 5.858

Review 9.  Epithelial Anion Transport as Modulator of Chemokine Signaling.

Authors:  Andrea Schnúr; Péter Hegyi; Simon Rousseau; Gergely L Lukacs; Guido Veit
Journal:  Mediators Inflamm       Date:  2016-06-12       Impact factor: 4.711

Review 10.  Saliva Proteomics as Fluid Signature of Inflammatory and Immune-Mediated Skin Diseases.

Authors:  Anna Campanati; Emanuela Martina; Federico Diotallevi; Giulia Radi; Andrea Marani; Davide Sartini; Monica Emanuelli; George Kontochristopoulos; Dimitris Rigopoulos; Stamatis Gregoriou; Annamaria Offidani
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.